Acalabrutinib (Calquence) yielded high efficacy and a manageable safety profile for the treatment of chronic lymphocytic leukemia (CLL) in older and/or frail patients, according to findings from the ...
Establishment Labs (ESTA) noted the publication of “The 3-Year Results of a 100-Patient Prospective Study of Safety and Effectiveness of Mia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback